Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
January 2005
2005:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2006 | 2007 | 2008
News | News in brief | News Features
News
Europe pares down double patents on breast-cancer gene
In battles worthy of a TV court drama, the European Patent Office (EPO) has slashed the scope of two patents on the breast-cancer gene BRCA1.
Nature (27 January 2005)
| Full Text |
Infection scare inflames fight against biodefence network
The accidental infection of three Boston University researchers with dangerous bacteria is raising questions about the US expansion of biodefence labs.
Nature (27 January 2005)
| Full Text |
Global vaccine project gets a shot in the arm
Two donors this week gave US $1 billion to a project that immunizes children in the world's poorest countries against preventable diseases such as hepatitis B and yellow fever.
Nature (27 January 2005)
| Full Text |
Georgia court bans biology textbook stickers
A court in Georgia has overturned a suburban Atlanta school policy that required a disclaimer about evolution to be placed in science textbooks.
Nature (20 January 2005)
| Full Text |
All parties on edge as NIH delays open-access briefing
The US National Institutes of Health (NIH) has cancelled a briefing on the final version of its new policy for open access to scientific literature — leaving the plan's supporters and opponents anxious about what happens next.
Nature (20 January 2005)
| Full Text |
Pasteur board quits in bid to resolve crisis at troubled institute
The board of directors of the Pasteur Institute in Paris has resigned en masse, in the latest twist in a bitter dispute between staff and management over the running of the institute.
Nature (20 January 2005)
| Full Text |
Science lobby urges UK to divert funds from military fields
A report released this week by Scientists for Global Responsibility (SGR) claims that public funding of science and technology in Britain is too focused on weapons-based research.
Nature (13 January 2005)
| Full Text |
European research framework set to expand
Officials in Brussels are drawing up plans for the European Union's Seventh Framework Program of Research (FP7), and the proposed scope may cheer the continent's scientists.
Nature (13 January 2005)
| Full Text |
Health rules may hamper Japanese import of lab mice
Japan is to introduce a new regulation for animal imports, in an effort to prevent outbreaks of diseases that could infect humans, but biologists worry that the rule will simply make it harder to do research.
Nature (13 January 2005)
| Full Text |
Science's next generation finds its own way
Young scientists from six continents celebrated in Marakkech the foundation of the World Academy of Young Scientists (WAYS), the first body to represent young researchers of all disciplines from every corner of the planet.
Nature (13 January 2005)
| Full Text |
Protein chip companies turn to biomarkers
A new proteomics chip claims to allow high throughput protein-interaction studies used in drug discovery.
Nature Biotechnology (January 2005)
| Full Text |
Delisting threat looms large on biotech front
Biotech companies are not able to sustain investor's interests due to immature pipeline.
Nature Biotechnology (January 2005)
| Full Text |
New patent rules drive Indian drug firms to research
An international patent agreement is compelling Indian drug companies to pump money into research and development (R&D), strike alliances with companies abroad and seek innovative ways to stay in business.
Nature Medicine (January 2005)
| Full Text |
US AIDS chief altered report on nevirapine safety risks
An AIDS drug used to block transmission between mothers and babies in Africa, can also promote drug-resistant forms of the virus, which can limit treatment options for the mothers at later times.
Nature Medicine (January 2005)
| Full Text |
Pandemic fears hatch new methods in flu vaccine industry
Spurred by warnings of an impending worldwide influenza epidemic, biotechnology companies are racing to develop faster ways to make flu vaccines.
Nature Medicine (January 2005)
| Full Text |
Allegations fly over fate of UK medical research institute
The head of the UK's Medical Research Council (MRC), is to be investigated after a senior scientist claimed that he was threatened with dismissal if he continued to oppose relocation plans for the National Institute for Medical Research (NIMR).
Nature Medicine (January 2005)
| Full Text |
Europe's new policies bail out ailing pharma companies
Emulating policies in the US, Europe is stepping up with new initiatives intended to close 'the pharmaceutical gap' created by its regulatory policies and a fragmented market.
Nature Medicine (January 2005)
| Full Text |
News in brief
Gender bias unveiled as big problem in Indian science
| Brain donation scheme probed in consent row
| Bioethics law restarts Korea's stem-cell work
| Government guidelines weigh in over obesity
| Boost for Indian science as advisory board is revived
| Oxford to bridge gap between faith and fact
| Open archive policy
| Conflicts at institute?
| FDA steps up safety
| Indian generics delisted
| French tax rebate
| US patent fee hike
| Global Fund delays funding cycle
| UN cloning ban shelved
| Generic manufacturers gain ground in patent fights
| US tightens belt for life sciences research
| New US health chief nominated
News Features
All pain, no gain?
Exercise is good for you, or so we always thought. But, as Alison Abbott learns, your genes don't always cooperate.
Nature (20 January 2005)
| Full Text |
The premier division
Since he took over as Harvard president in 2001, Larry Summers' style and vision have divided the university. As his plans for expansion step up a gear, Summers tells Helen Pearson why it is time for Cambridge to face up to the need for change.
Nature (20 January 2005)
| Full Text |
Vietnam's war on flu
Having suffered heavily from avian influenza in 2004, Vietnam might now be brewing the next human flu pandemic. Yet, as Peter Aldhous discovers, local researchers don't have the resources to investigate the risk properly.
Nature (13 January 2005)
| Full Text |
International patent law—boon or bane of biotech?
India and several other WTO-member countries are now compliant with international patent rights. Paroma Basu investigates the potential impact on biotech.
Nature Biotechnology (January 2005)
| Full Text |
Medicine of the masses
Viewed askance by scientists for decades, herbal remedies are finally entering the mainstream. Gunjan Sinha explores the new face of centuries-old medicine.
Nature Medicine (January 2005)
| Full Text |
|
